Topic Review
Skin Aging, Metabolism, and Related Products
Skin aging affects the metabolism of three major substances, which are glucose, protein, and lipids, and the metabolism of the three major substances in the skin also affects the process of skin aging. Some drugs or compounds can regulate the metabolic disorders mentioned above to exert anti-aging effects. Currently, there are a variety of products, but most of them focus on improving skin collagen levels. Skin aging is closely related to metabolism, and they interact with each other. Regulating specific metabolic disorders in the skin is an important anti-aging strategy.
  • 181
  • 19 Jan 2024
Topic Review
Neuralgic Amyotrophy and Hourglass Nerve Constriction/Nerve Torsion
Neuralgic amyotrophy, also called Parsonage–Turner syndrome, in its classic presentation is a brachial plexopathy or a multifocal neuropathy, involving mainly motor nerves of the upper limb with a monophasic course. Recently, a new radiological entity was described, the hourglass constriction, which is characterized by a very focal constriction of a nerve, or part of it, usually associated with nerve thickening proximally and distally to the constriction. Another condition, which is similar from a radiological point of view to hourglass constriction, is nerve torsion. The pathophysiology of neuralgic amyotrophy, hourglass constriction and nerve torsion is still poorly understood, and a generic role of inflammation is proposed for all these conditions.
  • 109
  • 19 Jan 2024
Topic Review
Role of Intestinal Microbiota in Celiac Disease Pathogenesis
The intestinal microbiota contributes to maintaining the integrity of the intestinal barrier, preventing the formation of a “leaky” intestine. On the contrary, a change in the composition of the microbiota can act as a significant link in the pathogenesis of gluten intolerance and exacerbate the course of the disease. The possibility of modulating the composition of the microbiota by prescribing probiotic preparations is being considered. The effectiveness of the use of probiotics containing Lactobacillus and Bifidobacterium bacteria in experimental and clinical studies as a preventive and therapeutic agent has been documented.
  • 99
  • 19 Jan 2024
Topic Review
Combination Drug Therapy for Chronic Neuropathic Pain
Chronic neuropathic pain (NP) is an increasingly prevalent disease and leading cause of disability which is challenging to treat. Several distinct classes of drugs are currently used for the treatment of chronic NP, but each drug targets only narrow components of the underlying pathophysiological mechanisms, bears limited efficacy, and comes with dose-limiting side effects. Multimodal therapies have been increasingly proposed as potential therapeutic approaches to target the multiple mechanisms underlying nociceptive transmission and modulation. However, while preclinical studies with combination therapies showed promise to improve efficacy over monotherapy, clinical trial data on their efficacy in specific populations are lacking and increased risk for adverse effects should be carefully considered. Drug-drug co-crystallization has emerged as an innovative pharmacological approach which can combine two or more different active pharmaceutical ingredients in a single crystal, optimizing pharmacokinetic and physicochemical characteristics of the native molecules, thus potentially capitalizing on the synergistic efficacy between classes of drugs while simplifying adherence and minimizing the risk of side effects by reducing the doses.
  • 116
  • 19 Jan 2024
Topic Review
Bacterial Vaginosis and Vulvovaginal Candidiasis
Among the infectious causes of vulvovaginal symptoms, bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) dominate. Apart from infrequent mixed infections, both are considered independent and caused by unrelated pathogenic mechanisms.
  • 125
  • 19 Jan 2024
Topic Review
Primary Resistance to EGFR Tyrosine Kinase Inhibitors
The discovery of the efficacy of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC) patients has revolutionized lung cancer therapy. Although almost all responders acquire drug resistance within a few years, many studies have revealed several acquired-resistant mechanisms and developed therapeutic strategies countervailing them, most notably against the EGFR T790M gatekeeper mutation. However, little progress has been made in terms of elucidating the mechanisms of primary resistance. Primary resistance may be defined into two types of resistance, clinically representing patients that do not respond (non-responders) to EGFR-TKIs.
  • 157
  • 19 Jan 2024
Topic Review
Medicinal Herbs as Immunomodulators for Infectious Diseases Treatment
The use of herbal medicines as remedies is very ancient and has been employed for centuries. Many studies have confirmed the antimicrobial activities of herbs against various pathogens in vitro and in vivo. The therapeutic effect of medicinal herbs is mainly attributed to the natural bioactive molecules present in these plants such as alkaloids, flavonoids, and terpenoids. 
  • 162
  • 19 Jan 2024
Topic Review
Plant Extracts as Skin Care and Therapeutic Agents
Natural ingredients have been used for centuries for skin treatment and care. Interest in the health effects of plants has recently increased due to their safety and applicability in the formulation of pharmaceuticals and cosmetics. Long-known plant materials as well as newly discovered ones are increasingly being used in natural products of plant origin. 
  • 220
  • 19 Jan 2024
Topic Review
Food Allergen Immunotherapy for IgE-Mediated Food Allergy Treatment
Implementation of an elimination diet is not a sufficient therapeutic strategy in patients with food allergy, whose quality of life is significantly impaired. In recent years, new effective therapeutic strategies have been developed, such as the application of oral, sublingual, and epicutaneous immunotherapy. Oral immunotherapy is the most often applied strategy because of its effectiveness and ease of application, with an acceptable safety profile. The effectiveness of oral immunotherapy in patients with egg, cow’s milk, and peanut allergy has been proven both in terms of raising of the threshold and the development of tolerance, and in some patients, the development of sustainable unresponsiveness. Although oral immunotherapy is an effective treatment for food allergy, several limitations, including a long duration and a significant rate of reported adverse events, reduces its success.
  • 95
  • 19 Jan 2024
Topic Review
Approaches to Estimate Minimum Clinically Important Differences
The origin of evidence-based medicine (EBM) dates back to the 1970s. This paradigm emphasizes a methodical evaluation of the evidence for use in health care decision-making, along with the knowledge of decision-makers and the expectations and values of patients. There is a growing awareness of correlating statistically significant results with clinical relevance in clinical trials to avoid the misinterpretation of study findings and prevent patients from being exposed to unnecessary therapies. The concept of “clinically important difference”, which has been developed as a way to overcome the drawbacks of a “statistically significant difference” and which represents a change that the patient feels, is noteworthy. The minimum clinically important difference (MCID) is the threshold value for such a change, first described by Jaeschke and colleagues in 1989. There has been a shift towards considering clinical relevance rather than just statistical significance in interpreting results from clinical trials. Multiple rating scales, such as the Modified Rankin Scale (mRS) and the Barthel Index (BI), are commonly used as outcome measures in both daily neurological practice and clinical trials, including stroke trials.
  • 156
  • 18 Jan 2024
  • Page
  • of
  • 1352
Video Production Service